AbbVie-Apogee deal on radar for US healthcare stocks next week
Healthcare stocks in the U.S. could move Monday after a report said AbbVie is nearing a $10.9 billion cash takeover of Apogee Therapeutics. That price would be about 60% over where Apogee ended Thursday. Neither company has confirmed a deal.